HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $15,108,944 | -2.8% | 177,460 | -5.5% | 0.09% | -8.4% |
Q1 2023 | $15,547,318 | -18.7% | 187,883 | -22.7% | 0.10% | -26.4% |
Q4 2022 | $19,121,624 | +2.2% | 243,123 | -3.8% | 0.13% | -12.8% |
Q3 2022 | $18,715,000 | +5.1% | 252,805 | -7.5% | 0.15% | +7.2% |
Q2 2022 | $17,813,000 | +1178.8% | 273,282 | +1140.6% | 0.14% | +1433.3% |
Q1 2022 | $1,393,000 | +136.5% | 22,029 | +329.4% | 0.01% | +50.0% |
Q4 2019 | $589,000 | -31.9% | 5,130 | -25.2% | 0.01% | -45.5% |
Q3 2019 | $865,000 | +54.2% | 6,860 | +47.2% | 0.01% | +37.5% |
Q2 2019 | $561,000 | +100.4% | 4,660 | +45.6% | 0.01% | +100.0% |
Q1 2019 | $280,000 | -61.5% | 3,200 | -56.0% | 0.00% | -69.2% |
Q4 2018 | $728,000 | -22.6% | 7,281 | -11.2% | 0.01% | 0.0% |
Q3 2018 | $940,000 | -81.2% | 8,201 | -85.3% | 0.01% | -83.5% |
Q2 2018 | $4,995,000 | +16.0% | 55,701 | -5.4% | 0.08% | +9.7% |
Q1 2018 | $4,307,000 | +1166.8% | 58,871 | +904.6% | 0.07% | +1100.0% |
Q4 2017 | $340,000 | +29.3% | 5,860 | 0.0% | 0.01% | +20.0% |
Q3 2017 | $263,000 | -45.2% | 5,860 | -64.6% | 0.01% | -50.0% |
Q2 2016 | $480,000 | -28.6% | 16,550 | -13.9% | 0.01% | -28.6% |
Q1 2016 | $672,000 | -40.6% | 19,212 | -45.3% | 0.01% | -36.4% |
Q4 2015 | $1,132,000 | +2.4% | 35,112 | +2.6% | 0.02% | -4.3% |
Q3 2015 | $1,106,000 | – | 34,232 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |